Monthly Update to the Canada Vigilance adverse reaction online database
he data presented in the Canada Vigilance Adverse Reaction Online Database has been updated and now includes information received by Health Canada up to April 30, 2026. The next update of data is scheduled for early September 2026.
Monthly update to the list of new safety and effectiveness reviews for health products
The list of new safety and effectiveness reviews has been updated and now includes safety reviews initiated between June 1 and 30, 2026. The next update is scheduled for September 2026.
Health Product InfoWatch, July 2026
Safety brief: Announcement: Ministerial Reliance Order; Vaccine safety summary: 2025 AEFI data; Safety brief: Carbamazepine and oxcarbazepine oral suspensions and the risk of propylene glycol toxicity.
Health Promotion and Chronic Disease Prevention in Canada, Vol 46, No 7/8, July/August 2026
Understanding the impact of climate change on mental health from a Canadian perspective: a scoping reviewl; Using health service data to understand unregulated toxic drug deaths in Alberta (2018â2023): an ecological study; Evolving student health priorities and school-based health-promoting interventions in Quebec, 2016â2025